Urocanate hydratase, also known as urocanase or imidazolonepropionate hydrolase, is an enzyme that catalyzes the hydration of urocanate to 4,5-dihydro-4-oxo-5-imidazolepropanoate, which is the second step in the degradation of histidine . It is encoded by the hutU gene in some bacteria . Recombinant Bdellovibrio bacteriovorus Urocanate hydratase (HutU), partial, refers to a partially produced form of this enzyme using recombinant DNA technology.
Urocanase (EC 4.2.1.49) is crucial in histidine catabolism . The enzyme utilizes two NAD+ (Nicotinamide Adenine Dinucleotide) groups to catalyze the hydrolysis of urocanate. These NAD+ groups act as electrophiles, attaching to the top carbon of the urocanate, leading to a sigmatropic rearrangement of the urocanate molecule. This rearrangement allows for the addition of a water molecule, converting urocanate into 4,5-dihydro-4-oxo-5-imidazolepropanoate .
The reaction is as follows:
$$
\text{urocanate} + H_2O \rightleftharpoons \text{4,5-dihydro-4-oxo-5-imidazolepropanoate}
$$
Urocanase is found in various organisms, including bacteria (gene hutU), the liver of many vertebrates, and plants such as Trifolium repens (white clover) . It is a protein of approximately 60 kDa that binds tightly to NAD+ and uses it as an electrophilic cofactor. A conserved cysteine residue is important for the catalytic mechanism and could be involved in the binding of NAD+ .
The hutU gene, encoding urocanase, is involved in the histidine utilization pathway in bacteria . Studies on the hutU gene in Pseudomonas syringae have shown that it is upregulated at lower temperatures, indicating its role in cold adaptation . The hutU mRNA contains a long 5'-untranslated region, a characteristic feature of many cold-inducible genes of mesophilic bacteria .
Recombinant urocanase is produced by cloning and expressing the hutU gene in a host organism, such as Escherichia coli . This allows for the production of large quantities of the enzyme for research and industrial applications. The recombinant protein can be engineered to enhance its stability, catalytic activity, or other desired properties.
A fast and efficient isolation procedure can yield electrophoretically homogeneous urocanase within two days. The yield of pure enzyme can be improved significantly compared with traditional methods .
Mutational analysis of urocanase has revealed the importance of specific amino acid residues in catalysis and cofactor binding. For example, studies have shown that Cys410 is essential for catalysis in Pseudomonas putida .
Urocanase and its inhibitors have potential applications in various fields:
Antimicrobial Agents: Urea derivatives, which can inhibit epoxide hydrolases, have shown promising growth inhibition against Acinetobacter baumannii .
Tuberculosis Treatment: Novel anti-tuberculosis agents with unique mechanisms of action are being developed using urea derivatives .
Industrial Applications: Recombinant urocanase can be used in the production of specific chemical compounds or in bioremediation processes.
Inherited deficiency of urocanase leads to elevated levels of urocanic acid in the urine, a condition known as urocanic aciduria .
KEGG: bba:Bd2751
STRING: 264462.Bd2751
Bdellovibrio bacteriovorus is a predatory deltaproteobacterium that invades and consumes other Gram-negative bacteria. It operates through a biphasic lifecycle consisting of a non-replicating attack phase (AP) where it searches for prey at high swimming speeds, and an intraperiplasmic phase (IP) lasting 3-4 hours where it invades prey, forms a bdelloplast, secretes hydrolytic enzymes, and utilizes prey nutrients for growth and replication .
Urocanate hydratase (HutU) is an enzyme in the histidine utilization pathway that catalyzes the conversion of urocanate to 4-imidazolone-5-propionate. This enzyme is particularly interesting in B. bacteriovorus because of its potential role in amino acid metabolism during the predatory cycle. Understanding HutU function may provide insights into how B. bacteriovorus processes nutrients derived from prey bacteria during its intraperiplasmic growth phase .
The predatory lifecycle of B. bacteriovorus creates unique challenges for protein expression studies. During the attack phase, approximately 33% of genes are transcribed, while this increases to 85% during the intraperiplasmic growth phase . This differential gene expression pattern means that:
Timing of sampling is critical for capturing the desired protein expression
Promoter selection must consider lifecycle-specific activation
Experimental design must account for the biphasic nature of growth
Protein yields may vary significantly depending on growth conditions
For recombinant hutU expression, researchers must consider whether the native protein is expressed primarily during attack or intraperiplasmic phase, as this will influence optimal expression system design. Studies have identified several robust promoters that are active during the attack phase of B. bacteriovorus, which can be leveraged for recombinant protein expression .
Several genetic tools have been developed for B. bacteriovorus manipulation:
Plasmid-based systems: IncQ-type plasmids have been shown to replicate autonomously in B. bacteriovorus, while IncP derivatives can be maintained via homologous recombination .
Promoter options: Four robust promoters active during the attack phase have been identified and characterized .
Riboswitch control systems: Theophylline-activated riboswitches have been successfully adapted to function in B. bacteriovorus, enabling conditional gene expression .
Chromosomal integration: Methods for inserting genetic constructs into the B. bacteriovorus chromosome have been established, allowing stable expression without antibiotic selection pressure .
For recombinant hutU expression specifically, researchers should consider using the native hutU promoter if expression timing is critical, or a constitutive promoter if continuous expression is desired. The Theo-F riboswitch system provides an option for inducible expression when experimental control is required .
Cultivation of B. bacteriovorus requires specific approaches due to its predatory lifestyle:
Host-Dependent Cultivation:
Host bacteria (typically E. coli S17-1 or Salmonella strains) are grown to late-log phase in suitable medium
Predator-prey ratio is typically maintained at 1:3 to 1:10 for optimal predation
Co-cultures are incubated at 28-30°C with vigorous shaking (200-250 rpm)
Clearance of prey (visible as culture clarification) indicates successful predation
Filtration through 0.45 μm filters separates B. bacteriovorus from remaining prey cells
Host-Independent (HI) Cultivation:
Spontaneous host-independent mutants occur at a frequency of 10⁻⁶ to 10⁻⁷, allowing axenic culture
HI variants typically show diminished predatory capabilities
Rich peptone-yeast extract medium is used for HI variant cultivation
These variants form smaller, more turbid plaques than wild-type strains on host lawns
For recombinant hutU expression, researchers should carefully consider whether host-dependent or host-independent cultivation is more appropriate, as this choice affects protein yields and experimental variables. Host-dependent cultivation more closely mimics natural conditions but introduces more variables, while HI cultivation offers simplified experimental design at the cost of potentially altered metabolism .
Based on available research, the following expression systems have proven effective for recombinant protein production in B. bacteriovorus:
| Vector Type | Replication in B. bacteriovorus | Stability | Advantages | Disadvantages |
|---|---|---|---|---|
| IncQ plasmids | Autonomous replication | Moderate | No integration required | May require antibiotic selection |
| IncP plasmids | Maintained via homologous recombination | High when integrated | Stable without selection | Requires homologous sequences |
| Chromosomal integration vectors | N/A - integrated into genome | Very high | Most stable expression | More complex construction |
For promoter selection, the following options have been characterized:
| Promoter | Expression Phase | Strength | Inducibility |
|---|---|---|---|
| P₂₉₁₅ (Bd2915 promoter) | Attack phase | Moderate | Constitutive |
| Attack phase-specific promoters | Attack phase | Strong | Constitutive |
| Theo-F riboswitch | Variable depending on upstream promoter | Controllable | Inducible with theophylline |
For recombinant hutU specifically, an effective approach would be to use an IncQ-based vector with the native hutU promoter if preserving natural expression patterns is desired, or a strong attack phase promoter coupled with a Theo-F riboswitch for controlled expression .
Urocanate hydratase activity can be measured through several approaches:
Spectrophotometric assay: Monitoring the decrease in absorbance at 277 nm as urocanate (substrate) is converted to imidazolonepropionate. This provides real-time kinetic data.
Coupled enzyme assays: Using downstream enzymes in the histidine utilization pathway to produce a detectable product.
HPLC analysis: Separating and quantifying substrate and product concentrations over time.
For comprehensive characterization, the following parameters should be determined:
Kinetic parameters: Km, Vmax, kcat, and kcat/Km to understand substrate affinity and catalytic efficiency
pH optimum: Typically between pH 7.0-8.5 for most bacterial urocanate hydratases
Temperature optimum: Often 30-37°C, but may vary for B. bacteriovorus
Cofactor requirements: Metal ion dependencies (often Mn²⁺ or Fe²⁺)
Substrate specificity: Testing structural analogs of urocanate
A sample experimental protocol would include:
Prepare reaction mixture containing buffer (typically 50 mM phosphate or Tris, pH 7.5), purified recombinant hutU (0.1-10 μg), and any required cofactors
Initiate reaction by adding urocanate (final concentration 10-500 μM)
Monitor absorbance decrease at 277 nm at 30-second intervals for 5-10 minutes
Calculate reaction rates at different substrate concentrations
Analyze data using Michaelis-Menten or Lineweaver-Burk plots to determine kinetic parameters
Structural comparison: Analyzing primary sequence conservation, tertiary structure predictions, and active site architecture. B. bacteriovorus proteins often show adaptations related to their predatory lifestyle.
Kinetic parameters comparison: B. bacteriovorus enzymes frequently display kinetic parameters optimized for function within the unique microenvironment of the prey's periplasm, which may differ from free-living bacteria.
Substrate specificity: Given B. bacteriovorus' specialized metabolism during predation, hutU may show altered substrate preferences compared to orthologs from other bacteria.
pH and temperature optima: These parameters might reflect adaptation to the prey periplasmic environment during the intraperiplasmic growth phase.
A comprehensive comparison should include enzyme characterization under identical conditions across multiple species, including E. coli (well-characterized model), Pseudomonas (environmental bacterium), and Salmonella (potential prey).
As a component of the histidine utilization pathway, hutU likely plays a significant role in amino acid metabolism during predation. During the intraperiplasmic growth phase, B. bacteriovorus secretes a cocktail of hydrolases to digest prey cellular components, including proteins . The resulting amino acids, including histidine, must then be metabolized.
Potential roles for hutU during predation include:
Nutrient acquisition: Converting histidine-derived metabolites to compounds that can enter central metabolism
Energy generation: The histidine utilization pathway can contribute to ATP production
Nitrogen recycling: Processing amino nitrogen for use in biosynthetic pathways
Research approaches to investigate these roles could include:
Gene knockout studies to assess growth impacts during predation
Transcriptomic analysis comparing hutU expression across different growth phases
Metabolomic profiling to track histidine metabolism during prey consumption
Isotope labeling studies to trace carbon and nitrogen flux through the pathway
The high transcriptional activity (up to 85% of genes) during the intraperiplasmic growth phase suggests that metabolic enzymes like hutU play crucial roles during this predatory stage .
Advanced structural biology techniques can provide valuable insights into B. bacteriovorus hutU function:
X-ray crystallography: Determining high-resolution structures of hutU in different states (apo, substrate-bound, product-bound) can reveal:
Active site architecture and catalytic mechanism
Conformational changes during catalysis
Potential allosteric regulation sites
Structural adaptations unique to B. bacteriovorus
Cryo-electron microscopy (cryo-EM): Particularly useful for examining hutU in complex with other proteins or large assemblies.
Nuclear Magnetic Resonance (NMR) spectroscopy: Provides insights into protein dynamics in solution, which may be critical for understanding hutU function during predation.
Molecular dynamics simulations: Computational approach to model protein behavior under different conditions, such as the prey periplasmic environment.
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Can reveal regions of conformational flexibility and solvent accessibility relevant to function.
These approaches should be combined with functional assays to correlate structural features with enzymatic activity. For example, site-directed mutagenesis of residues identified in structural studies can validate their importance for catalysis or substrate binding.
Several challenges specific to B. bacteriovorus protein expression systems must be considered:
Prey contamination: When using host-dependent cultivation, prey proteins can contaminate preparations.
Solution: Implement multi-step purification protocols and consider expression in host-independent variants.
Predatory lifestyle interference: Overexpression of non-native proteins may interfere with the predatory lifecycle.
Codon usage bias: B. bacteriovorus has distinct codon preferences.
Solution: Optimize codons in recombinant constructs for B. bacteriovorus expression.
Low transformation efficiency: Genetic manipulation of B. bacteriovorus is challenging.
RNase activity: High levels of nuclease activity can destabilize plasmids.
Solution: Include appropriate stabilizing elements in vector design.
A systematic approach to troubleshooting would include:
Verifying construct integrity before and after transformation
Confirming expression using both activity assays and Western blotting
Testing multiple promoter and ribosome binding site combinations
Optimizing induction conditions when using regulated systems
Exploring alternative growth conditions to improve yield
Optimizing purity and yield requires consideration of B. bacteriovorus-specific factors:
Purification strategy optimization:
| Purification Step | Method | Consideration for B. bacteriovorus |
|---|---|---|
| Cell lysis | Sonication or French press | Must ensure complete lysis of predatory cells |
| Initial capture | Affinity chromatography (His-tag) | Tag position can affect predatory protein folding |
| Intermediate purification | Ion exchange chromatography | Consider predicted pI of B. bacteriovorus hutU |
| Polishing | Size exclusion chromatography | Critical for removing prey protein contaminants |
Yield optimization approaches:
Growth condition optimization:
Test both host-dependent and host-independent cultivation
Optimize predator:prey ratios (for host-dependent growth)
Determine optimal harvest time based on hutU expression profile
Expression system refinement:
Solubility enhancement:
Co-express with molecular chaperones if needed
Test expression at lower temperatures (20-25°C)
Consider fusion partners known to enhance solubility
Stabilization during purification:
Include appropriate protease inhibitors
Maintain consistent cold temperature throughout processing
Add stabilizing agents (glycerol, reducing agents) to buffers
Typical yield expectations would be 0.5-5 mg of purified protein per liter of B. bacteriovorus culture, depending on expression system optimization.
Activity loss in purified recombinant hutU can result from several factors:
Oxidation of critical residues: Urocanate hydratases often contain oxidation-sensitive residues.
Diagnostic: Compare activity with and without reducing agents
Solution: Include reducing agents (DTT, β-mercaptoethanol) in buffers
Metal cofactor loss: If hutU requires metal cofactors (common for this enzyme class).
Diagnostic: Test activity restoration with different metal ions
Solution: Include appropriate metal ions (Mn²⁺, Fe²⁺) in storage buffers
Protein aggregation: Detectable by size exclusion chromatography or dynamic light scattering.
Diagnostic: Analyze by non-denaturing PAGE or analytical SEC
Solution: Optimize buffer conditions (pH, ionic strength, additives)
Proteolytic degradation: B. bacteriovorus produces numerous proteases.
Diagnostic: Analyze by SDS-PAGE over time
Solution: Use additional protease inhibitors and optimize purification speed
Conformational changes: Loss of native structure during purification.
Diagnostic: Compare circular dichroism spectra with active preparations
Solution: Minimize exposure to extreme pH or temperature
A systematic troubleshooting approach should include:
Activity testing at each purification step to isolate where activity loss occurs
Stability testing under various storage conditions
Comparison of multiple purification strategies
Analysis of protein integrity by multiple methods (SDS-PAGE, Western blot, mass spectrometry)
Recombinant hutU from B. bacteriovorus offers several potential applications:
Biocatalysis: Urocanate hydratase catalyzes a stereospecific hydration reaction that could be valuable for producing chiral intermediates in pharmaceutical synthesis.
Biosensors: The specific interaction between hutU and its substrate could be leveraged to develop biosensors for histidine or urocanate detection.
Metabolic engineering: Integration into engineered pathways for histidine utilization or specialized metabolite production.
Comparative enzymology: As a predatory bacterium with unique evolutionary pressures, B. bacteriovorus hutU may have distinct catalytic properties worthy of investigation.
Developing these applications requires:
Comprehensive biochemical characterization
Engineering for stability outside the native cellular environment
Process optimization for specific applications
Integration with other enzymatic systems where appropriate
The unique evolutionary adaptations of B. bacteriovorus enzymes may provide advantages in certain applications compared to enzymes from conventional sources.
The successful expression of recombinant proteins like hutU provides valuable insights into genetic tool development for B. bacteriovorus:
Promoter characterization: Studies have identified robust promoters active during specific lifecycle phases, with four promoters specifically characterized for the attack phase .
Riboswitch functionality: The successful adaptation of theophylline-activated riboswitches demonstrates that RNA-based regulatory elements can function in B. bacteriovorus .
Plasmid compatibility: IncQ-type plasmids have been shown to replicate autonomously in B. bacteriovorus, while IncP derivatives require homologous recombination for maintenance .
Chromosomal integration: Methods for stable integration of genetic constructs have been developed, providing alternatives to plasmid-based expression .
Expression optimization: Ribosome binding site optimization specific for B. bacteriovorus has been implemented using computational tools like the RBS Calculator .
These insights contribute to a growing toolkit for genetic manipulation of this predatory bacterium, which has significant potential for biotechnological and biomedical applications such as biocontrol of pathogens .